Published in Clin Neuropharmacol on January 01, 1985
Parkinson's disease: disability, review, and management. Br Med J (Clin Res Ed) (1986) 1.66
Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy. J Bioenerg Biomembr (2009) 0.92
Nociceptive behavioral responses to chemical, thermal and mechanical stimulation after unilateral, intrastriatal administration of 6-hydroxydopamine. Brain Res (2008) 0.83
Measurement of the quality of life in congestive heart failure-Influence of drug therapy. Cardiovasc Drugs Ther (1988) 0.75
The Oswestry low back pain disability questionnaire. Physiotherapy (1980) 16.94
Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature (1998) 8.75
Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J (1973) 5.65
The effects of antihypertensive therapy on the quality of life. N Engl J Med (1986) 5.32
White-coat hypertension as a cause of cardiovascular dysfunction. Lancet (1996) 4.68
Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. Am J Epidemiol (1973) 3.77
A symptom questionnaire for hypertensive patients. J Chronic Dis (1974) 3.51
Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med (1999) 3.43
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet (1998) 3.41
Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther (1976) 3.13
25 years' experience with lymphangiomas in children. J Pediatr Surg (1999) 2.85
Analysis of the pressor dose response. Clin Pharmacol Ther (1982) 2.44
Immediate cardiovascular responses to oral prazosin--effects of concurrent beta-blockers. Clin Pharmacol Ther (1981) 2.36
Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. Science (1989) 2.25
Computer-based hypertension clinic records: a co-operative study. Br Med J (1974) 2.24
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J (1999) 2.23
Confidence intervals. Lancet (1987) 2.21
Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group. N Engl J Med (1992) 2.17
Randomised controlled trial of computer-held medical records in hypertensive patients. Br Med J (1976) 2.15
Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J (1976) 2.13
Myopathy, osteomalacia and hyperparathyroidism. Brain (1967) 2.11
Low-carbohydrate diets: nutritional and physiological aspects. Obes Rev (2006) 2.09
A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects. Br J Clin Pharmacol (1982) 2.06
Dark hair follicle dystrophy in a border collie. Vet Rec (1994) 2.06
Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community. Br J Ophthalmol (2002) 2.03
Practice parameters for the assessment and treatment of anxiety disorders. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry (1993) 2.03
Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet (1983) 2.03
Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet (1977) 2.01
Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation (2000) 1.98
Topographic detection of photorefractive keratectomy. Ophthalmology (1998) 1.97
Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging (Milano) (1991) 1.93
Coordinating and standardizing long-term care: evaluation of the west of Scotland shared-care scheme for hypertension. Br J Gen Pract (1994) 1.92
Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine. Clin Pharmacol Ther (1977) 1.91
The biology of Dipetalonema proechimyis Esslinger, 1974 (Nematoda: Filarioidea) in Trinidad. J Parasitol (1974) 1.89
Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man. Br J Clin Pharmacol (1983) 1.89
Respiratory symptoms in Tasmanian adolescents: a follow up of the 1961 birth cohort. Aust N Z J Med (1984) 1.88
Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review. Health Technol Assess (2001) 1.87
Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521. Br J Clin Pharmacol (1982) 1.81
Effect of intravenous adrenaline on electrocardiogram, blood pressure, and serum potassium. Br Heart J (1983) 1.79
Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. Br J Ophthalmol (1975) 1.79
Area deprivation, social class, and quality of life among people aged 75 years and over in Britain. Int J Epidemiol (2005) 1.79
Association between intraocular pressure and loss of visual field in chronic simple glaucoma. Br J Ophthalmol (1990) 1.76
How far should blood pressure be lowered? N Engl J Med (1992) 1.76
The drug treatment of hypertension. Practitioner (1971) 1.75
The retinal blood flow in diabetes. Diabetologia (1975) 1.72
Experimental retinal branch vein occlusion. Am J Ophthalmol (1970) 1.72
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic. Br Med J (Clin Res Ed) (1984) 1.69
Fibrinogen: a possible link between social class and coronary heart disease. Br Med J (Clin Res Ed) (1985) 1.67
The MRC trial of assessment and management of older people in the community: objectives, design and interventions [ISRCTN23494848]. BMC Health Serv Res (2002) 1.67
Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol Cell Neurosci (2000) 1.66
Cardiovascular reflexes in Parkinsonism. Clin Sci (1971) 1.62
Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa. Br Med J (1971) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
How obstetricians manage hypertension in pregnancy. Br Med J (1978) 1.56
Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. J Pharmacol Exp Ther (1975) 1.56
The effects of cardioselective and non-selective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man. Clin Sci (Lond) (1983) 1.56
Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine. Hypertension (1992) 1.53
The prognosis of falls in elderly people living at home. Age Ageing (1999) 1.52
Evidence of parasympathetic activity of the angiotensin converting enzyme inhibitor, captopril, in normotensive man. Clin Sci (Lond) (1985) 1.49
Cereal grains and legumes in the prevention of coronary heart disease and stroke: a review of the literature. Eur J Clin Nutr (2006) 1.49
Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics. Br Heart J (1980) 1.49
Is aspirin safe for patients with heart failure? Br Heart J (1995) 1.49
Prognosis in adult asthma: a national study. Br Med J (Clin Res Ed) (1987) 1.49
Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.48
The JAK2 V617F mutation is detectable in granulocyte populations at greater than two copies per cell among individuals with myeloproliferative disorders. Leukemia (2007) 1.47
Verapamil pharmacokinetics and apparent hepatic and renal blood flow. Br J Clin Pharmacol (1985) 1.46
Vitamin C and blood pressure. J Hypertens (1990) 1.46
Blood pressure measurement in patients with rate controlled atrial fibrillation using mercury sphygmomanometer and Omron HEM-750CP deice in the clinic setting. J Hum Hypertens (2006) 1.45
Central hypotensive effect of propranolol in the rabbit. Br J Pharmacol (1973) 1.44
Trial of combination of guanethidine and oxprenolol in hypertension. Br Med J (1976) 1.44
Calcium channel blockers, ACE inhibitors, and the risk of cancer in hypertensive patients: a report from the Department of Health Hypertension Care Computing Project (DHCCP) J Hum Hypertens (2000) 1.44
Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension (1999) 1.44
The importance of central adrenergic neurones in renal hypertension in rabbits. J Physiol (1974) 1.43
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Alcohol problems among women in a general hospital ward. Br J Addict (1991) 1.39
Lower urinary tract dysfunction in Parkinson's disease: changes relate to age and not disease. Age Ageing (1995) 1.39
Salt intake and blood pressure in the general population: a controlled intervention trial in two towns. J Hypertens (1988) 1.39
Analgesia and satisfaction in childbirth (the Queen Charlotte's 1000 Mother Survey). Lancet (1982) 1.39
Standardization of criteria for assessing the effect of Simulium control in onchocerciasis control programmes. Trans R Soc Trop Med Hyg (1978) 1.38
Synthetic, structural and biological studies of the ubiquitin system: the total chemical synthesis of ubiquitin. Biochem J (1994) 1.38
Controlling hypertension in the elderly. QJM (2000) 1.37
Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man. Gut (1984) 1.36
Tyrosine hydrogen bonds make a large contribution to protein stability. J Mol Biol (2001) 1.36
Side effects of therapy in diabetes evaluated by a self-administered questionnaire. J Chronic Dis (1977) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Selective recording in blood pressure readings may increase subsequent mortality. QJM (2002) 1.33
Environmental factors affecting paracetamol metabolism in London factory and office workers. Br J Clin Pharmacol (1980) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Alterations in the transport and processing of Rous sarcoma virus envelope glycoproteins mutated in the signal and anchor regions. J Cell Biochem (1983) 1.31
Technical report: quantitative assessment of diaphragmatic movement--a reproducible method using ultrasound. Clin Radiol (1992) 1.30
Characterization of a replicating and packaged defective RNA of avian coronavirus infectious bronchitis virus. Virology (1994) 1.30
Desmethylimipramine and the hypotensive action of clonidine in the rabbit. Br J Pharmacol (1972) 1.30
Acute and chronic effects of the converting enzyme inhibitors enalapril and lisinopril on reflex control of heart rate in normotensive man. J Hypertens (1985) 1.29
The effect of captopril on the reflex control heart rate: possible mechanisms. Br J Clin Pharmacol (1985) 1.29
Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry (2002) 1.28
Could Parkinson's disease follow intra-uterine influenza?: a speculative hypothesis. J Neurol Neurosurg Psychiatry (1988) 1.28